When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Doença celíaca

Última revisión: 14 Aug 2025
Última actualización: 05 Mar 2025

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • diarreia
  • distensão abdominal
  • dor/desconforto abdominal
  • anemia
  • Deficiência de imunoglobulina (IgA)
  • dermatite herpetiforme
Todos los datos

Otros factores de diagnóstico

  • história familiar
  • osteopenia/osteoporose
  • fadiga
  • perda de peso
  • retardo do crescimento pôndero-estatural
  • diabetes do tipo 1
  • doença tireoidiana autoimune
  • estomatite aftosa
  • hipoplasia do esmalte dental
  • hematomas frequentes
  • neuropatia periférica
  • ataxia
  • elevação inexplicada dos níveis de aminotransferase sérica
  • diagnóstico de comorbidade psiquiátrica
Todos los datos

Factores de riesgo

  • história familiar de doença celíaca
  • deficiência de imunoglobulina A
  • diabetes do tipo 1
  • doença tireoidiana autoimune
  • Síndrome de Down
  • Síndrome de Turner
  • Síndrome de Sjögren
  • doença inflamatória intestinal
  • colangite biliar primária
  • psoríase
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • imunoglobulina A-transglutaminase tecidual (IgA-tTG)
  • IgA quantitativa
  • IgG peptídeo de gliadina desamidada (DGP)
  • Hemograma completo
  • anticorpo antiendomísio (EMA)
  • biópsia de pele
  • endoscopia do intestino delgado
  • histologia do intestino delgado
Todos los datos

Pruebas diagnósticas que deben considerarse

  • tipagem do antígeno leucocitário humano (HLA)
  • teste de provocação com glúten
  • videoendoscopia por cápsula
Todos los datos

Algoritmo de tratamiento

En curso

doença celíaca

falha ao responder à terapia/doença celíaca refratária

crise celíaca

Colaboradores

Autores

Amelie Therrien, MD

Gastroenterologist, Celiac Center

Instructor in Medicine, Harvard Medical School

Beth Israel Deaconess Medical Center

Boston

MA

Divulgaciones

AT is a site principal investigator for National Institute of Allergy and Infectious Diseases NIAID (IMX003 [latiglutenase]).

Benjamin Lebwohl, MD, MS

Associate Professor of Medicine and Epidemiology

Columbia University Irving Medical Center

New York

NY

Divulgaciones

BL is an unpaid advisor for Nima Partners, Takeda, Teva, 9 Meters Biopharma, Bristol Myers Squibb, Mozart Therapeutics, and Alimentiv and a contractual researcher for Anokion. BL is an author of several references in this topic.

Agradecimientos

Dr Amelie Therrien and Dr Benjamin Lebwohl would like to gratefully acknowledge Professor Ciaran P. Kelly and Dr Daniel A. Leffler, previous contributors to this topic.

Divulgaciones

DAL declares that he has no competing interests. CPK is a scientific advisor/consultant for Cour Pharma, Glutenostics, Immunogenx, Innovate, and Takeda Pharmaceuticals. He is an investigator for Aptalis and Takeda, and has stock options in Cour Pharma and Glutenostics. CPK is also a co-author of several references cited in this topic.

Revisores por pares

Matthew Kurien, PGDip MedSci, MD, MBChB, MRCP

Senior Clinical Lecturer and Honorary Consultant Gastroenterologist

Department of Infection, Immunity & Cardiovascular Disease

Sheffield Medical School

Sheffield

UK

Divulgaciones

MK declares that he has no competing interests.

Eli D. Ehrenpreis, MD

Professor of Medicine

Rosalind Franklin Medical School

Chicago

IL

Divulgaciones

EDE declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613.Texto completo  Resumen

van der Windt DA, Jellema P, Mulder CJ, et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010 May 5;303(17):1738-46.Texto completo  Resumen

Chaudrey KH. ACG guideline: diagnosis and management of celiac disease. Am J Gastroenterol. 2023;118(1):23. Resumen

Husby S, Koletzko S, Korponay-Szabó I, et al. European Society for Paediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr. 2020 Jan;70(1):141-56.Texto completo  Resumen

National Institute for Health and Care Excellence. Coeliac disease: recognition, assessment and management. Sep 2015 [internet publication].Texto completo

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Doença celíaca images
  • Diferenciales

    • Duodenite péptica
    • Doença de Crohn
    • Giardíase
    Más Diferenciales
  • Guías de práctica clínica

    • Diagnosis and management of celiac disease
    • Coeliac disease: recognition, assessment and management
    Más Guías de práctica clínica
  • Folletos para el paciente

    Doença celíaca

    Más Folletos para el paciente
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad